NASDAQ:IRWD

Ironwood Pharmaceuticals Stock Predictions

Healthcare > Drug Manufacturers - Specialty & Generic

Buy IRWD

*Your capital is at risk

$3.24

-0.0400 (-1.22%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

IRWD Prediction Chart

IRWD Predictions History

Latest community submissions for IRWD.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
coralli Merchant	Jun 1, 2020	$9.74 +0.15%	$9.73	X	99.85%	6
NameNotImportant Pro	May 6, 2019	$10.77 +1.41%	$10.62	X	98.59%	1
NameNotImportant Pro	May 3, 2019	$10.15 -4.34%	$10.61	X	95.66%	0
NameNotImportant Pro	May 2, 2019	$11.49 +11.88%	$10.27	X	88.12%	0
NameNotImportant Pro	May 1, 2019	$10.94 -7.13%	$11.78	X	92.87%	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for IRWD with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT IRONWOOD PHARMACEUTICALS

Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZESS name in the United States and Mexico, as well as under the CONSTELLA name in the Canada and European...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
RUN $12.83	18.86%	May 06
GLBE $31.61	5.35%	May 05
SAP $172.39	10.69%	May 05
W WCLD $27.34	27.18%	Apr 29
ADBE $243.57	7.61%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by